INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 October 2014
Net Assets |
£224m |
Net Assets per share |
447p |
Share price |
386p |
Total value of unquoted investments |
£17m |
Total number of portfolio companies |
83 |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
8.7 |
Gilead |
8.4 |
Regeneron |
7.4 |
Alexion |
5.4 |
Amgen |
4.8 |
Biogen-Idec |
4.0 |
Illumina |
3.8 |
Chimerix |
3.5 |
Biomarin |
3.2 |
Actelion |
2.9 |
|
----------- |
Total |
52.1 |
Portfolio Profitability |
% NAV |
Profitable |
57 |
Turning Profitable 2015 |
7 |
Unprofitable |
36 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
93 |
Europe & UK |
7 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
88 |
Unquoted |
12 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
27 NOVEMBER 2014